![Sandra E. Poole](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 2 M $ al 30/06/2026
Sandra E.
Poole is currently an Independent Director at Travere Therapeutics, Inc. since 2019 and Chief Operating Officer at Mythic Therapeutics, Inc. since 2020.
Former positions include Director at ViaCyte, Inc. from 2019 to 2022; Managing Director at S.
Poole Consulting LLC from 2017 to 2018; EVP-Technical Operations & Commercial Development at ImmunoGen, Inc. from 2016 to 2017; Senior Vice President-Biologics Manufacturing at Genzyme Corp.
from 2013 to 2014; Chief Operating Officer at Candel Therapeutics, Inc. in 2020; Member-Supervisory Board at Valneva SE from 2017 to 2020; and Chief Operating Officer at LogicBio Therapeutics, Inc. from 2018 to 2019.
Education includes undergraduate and graduate degrees from The University of Waterloo, conferred in 1989 and 1990 respectively.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 19/05/2026 | 34.000 ( 0,04 % ) | 2 M $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Director/Miembro de la Junta | 13/05/2019 |
Mythic Therapeutics, Inc.
 Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Director de Operaciones | 01/07/2020 |
| Empresas | Cargo | Fin |
|---|---|---|
ViaCyte, Inc.
 ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Director/Miembro de la Junta | 01/07/2022 |
| VALNEVA SE | Director/Miembro de la Junta | 17/06/2020 |
| CANDEL THERAPEUTICS, INC. | Director de Operaciones | 01/03/2020 |
| LOGICBIO THERAPEUTICS, INC. | Director de Operaciones | 31/03/2019 |
S. Poole Consulting LLC
 S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Corporate Officer/Principal | 01/03/2018 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 10 |
|---|---|
ImmunoGen, Inc.
 ImmunoGen, Inc. BiotechnologyHealth Technology Develops anticancer therapeutics | Health Technology |
Genzyme Corp.
 Genzyme Corp. Pharmaceuticals: MajorHealth Technology Develops and manufactures therapies for rare diseases, multiple sclerosis, immunology & oncology | Health Technology |
ViaCyte, Inc.
ViaCyte, Inc. Pharmaceuticals: MajorHealth Technology Develops transformative medicines for people with serious diseases | Health Technology |
The University of Waterloo
 The University of Waterloo Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Candel Therapeutics, Inc.
 Candel Therapeutics, Inc. BiotechnologyHealth Technology Develops and distributes immunotherapies for the treatment of cancer | Health Technology |
Valneva SE
 Valneva SE BiotechnologyHealth Technology Develops and commercializes of prophylactic vaccines for infectious diseases | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
LogicBio Therapeutics, Inc.
 LogicBio Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and commercializes medicines and therapies for bone metabolism, cardiology, neurology and rare diseases | Health Technology |
S. Poole Consulting LLC
S. Poole Consulting LLC Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Mythic Therapeutics, Inc.
Mythic Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company which develops cancer therapeutics | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
